|
ZNF559 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.771960E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.403010E-01 |
| Normal-vs-Stage2 |
9.720400E-03 |
| Normal-vs-Stage3 |
6.00499999947601E-07 |
| Normal-vs-Stage4 |
1.53989998530335E-09 |
| Stage1-vs-Stage2 |
8.028400E-02 |
| Stage1-vs-Stage3 |
1.83771999999749E-05 |
| Stage1-vs-Stage4 |
1.66760000253063E-08 |
| Stage2-vs-Stage3 |
3.191200E-01 |
| Stage2-vs-Stage4 |
4.261800E-02 |
| Stage3-vs-Stage4 |
1.203650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.19229999999638E-05 |
| Normal-vs-AfricanAmerican |
2.403400E-01 |
| Normal-vs-Asian |
8.717400E-01 |
| Caucasian-vs-AfricanAmerican |
9.754200E-02 |
| Caucasian-vs-Asian |
3.320600E-01 |
| AfricanAmerican-vs-Asian |
7.773000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59325999999904E-05 |
| Normal-vs-Female |
5.059700E-02 |
| Male-vs-Female |
6.255700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.014430E-01 |
| Normal-vs-Age(41-60Yrs) |
8.618400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.64479999999312E-05 |
| Normal-vs-Age(81-100Yrs) |
8.580900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.940600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.135200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.484000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.194300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.923800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.070400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.698300E-02 |
| Normal-vs-Grade 2 |
6.977200E-01 |
| Normal-vs-Grade 3 |
7.57260000261439E-08 |
| Normal-vs-Grade 4 |
2.12374562380546E-12 |
| Grade 1-vs-Grade 2 |
1.150590E-01 |
| Grade 1-vs-Grade 3 |
1.7465999999966E-05 |
| Grade 1-vs-Grade 4 |
2.78800005304447E-09 |
| Grade 2-vs-Grade 3 |
6.67420008149122E-10 |
| Grade 2-vs-Grade 4 |
5.44009282066327E-15 |
| Grade 3-vs-Grade 4 |
1.038640E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.544000E-01 |
| Normal-vs-ccB subtype |
1.43009999997723E-06 |
| ccA subtype-vs-ccB subtype |
4.93930000000642E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.018200E-04 |
| Normal-vs-N1 |
4.56930000503064E-08 |
| N0-vs-N1 |
1.375590E-04 |
|
|
